A new antigen retrieval technique for human brain tissue.

Immunohistochemical staining of tissues is a powerful tool used to delineate the presence or absence of an antigen. During the last 30 years, antigen visualization in human brain tissue has been significantly limited by the masking effect of fixatives. In the present study, we have used a new method for antigen retrieval in formalin-fixed human brain tissue and examined the effectiveness of this protocol to reveal masked antigens in tissues with both short and long formalin fixation times. This new method, which is based on the use of citraconic acid, has not been previously utilized in brain tissue although it has been employed in various other tissues such as tonsil, ovary, skin, lymph node, stomach, breast, colon, lung and thymus. Thus, we reported here a novel method to carry out immunohistochemical studies in free-floating human brain sections. Since fixation of brain tissue specimens in formaldehyde is a commonly method used in brain banks, this new antigen retrieval method could facilitate immunohistochemical studies of brains with prolonged formalin fixation times

Solutions to Avoid False Positives for Rituximab in Pre-Transplant Crossmatches

Rituximab (anti-CD20) is commonly used as immunotherapy against B cells, in the context of pre-transplant crossmatches, where the presence of rituximab in the tested sera with donor cells can alter their results both by flow cytometry (FCXM) as complement-dependent cytotoxicity (CDCXM) giving rise to false positives. In the present study, we tested the use of an anti-rituximab monoclonal antibody (10C5, Abnova) as a method to avoid false positives in FCXM and CDCXM. We used the serum from ten patients who received therapy with rituximab, and the cells were incubated with sera treated or untreated with the 10C5 clone. In previous studies, attempts have been made to control these false positives through the use of pronase, although in these cases the alteration of Human Leukocyte Antigen (HLA) molecules has been found to be a limitation. As an alternative, we performed an assay to exclude false positives by a pre-incubation with anti-rituximab antibody (10C5) in 1:5 proportion avoiding the misinterpretation of crossmatches, particularly in patients with specific donor antibodies (DSA) without affecting the HLA molecules

A, Neuropeptide immunohistochemistry in the human thalamus.

<p>Bright field photomicrographs in high magnification of SP fibers without citraconic anhydride solution in the anteroventral thalamic nucleus. B, bright field photomicrographs in high magnification of SP fibers with citraconic anhydride solution in the same nucleus. Note the enhancement in the intensity of SP-ir fibers and in the number of fibers. Scale bar: 25 µm.</p

A, Immunohistochemistry for ENK in the caudate nucleus.

<p>Bright field photomicrographs in high magnification of ENK fibers without citraconic anhydride solution in the caudate nucleus. B, bright field photomicrographs in high magnification of ENK fibers with citraconic anhydride solution in the same nucleus. Note that the latter fibers are better delineated than in the conventional immunostaing method. Scale bar: 50 µm.</p

A–B, Immunohistochemistry for TH in the substantia nigra.

<p>High power view (10× and 20× magnification respectively) of TH-ir neurons in the substantia nigra employing the citraconic anhydride solution. Note the enhancement in the intensity and morphology (somas more preserved and processes more delineated) compared to the conventional immunostaining method (C–D). Scale bar: A and C 100 µm; B and D 50 µm.</p

A, Immunohistochemistry for CB in the MD.

<p>High power view of some CB-ir neurons in the human mediodorsal thalamic nucleus without the employ of citraconic anhydride solution. B, high power view of CB-ir neurons in the same nucleus employing the citraconic anhydride solution. Note the enhancement in the intensity of CB-ir somata. Scale bar: 50 µm.</p

A, Interneuron immunohistochemistry in the MD.

<p>High power view of some GAD-ir neurons in the mediodorsal thalamic nucleus without the use of citraconic anhydride solution. B, high power view of a GAD-ir neuron in the mediodorsal thalamic nucleus utilizing the citraconic anhydride solution. Scale bar: 25 µm.</p

Data of the human specimen used in this study.

<p>Data of the human specimen used in this study.</p